Indi Announces $47.25 Million in Funding for Blockbuster Diagnostic

Baird Capital, the direct private investment arm of Robert W. Baird & Co., announced today that its Venture Capital group has led a Series B financing round for Integrated Diagnostics, a molecular diagnostics company pioneering the use of blood-based proteomic tests.

Read the full release.